J-GLOBAL ID:202001011630752548   Update date: Apr. 15, 2024

Matsuoka Katsuyoshi

マツオカ カツヨシ | Matsuoka Katsuyoshi
Affiliation and department:
Job title: Professor
Research theme for competitive and other funds  (6):
  • 2021 - 2024 腸管と脾臓のクロストーク~全身性疾患としての炎症性腸疾患~
  • 2017 - 2022 Role of oral-care in inflammatory bowel disease patients in remission: an oral and intestinal bacteria-based study
  • 2017 - 2019 Development of hybrid intestine system and its applications
  • 2013 - 2016 Identification of the pathogenic virus of ulcerative colitis using the next-generation sequencing techonology
  • 2010 - 2012 Bactericidal function of neutrophils in Crohn`s disease
Show all
Papers (20):
  • Matsuoka K, Fujii T, Okamoto R, Yamada A, Kunisaki R, Matsuura M, Watanabe K, Shiga H, Takatsu N, Bamba S, et al. Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD). Journal of gastroenterology. 2022. 57. 867-878
  • Matsuoka K, Hisamatsu T, Kim HJ, Ye BD, Arai S, Hoshi M, Yuasa H, Tabira J, Toyoizumi S, Shi N, et al. Safety and efficacy of long-term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open. Journal of gastroenterology and hepatology. 2022. 37. 1884-1892
  • Okabayashi S, Yamazaki H, Yamamoto R, Anan K, Matsuoka K, Kobayashi T, Shinzaki S, Honzawa Y, Kataoka Y, Tsujimoto Y, et al. Certolizumab pegol for maintenance of medically induced remission in Crohn's disease. The Cochrane database of systematic reviews. 2022. 6. CD013747
  • Matsuoka K, Nagano K, Nagasaki S, Murata Y, Hisamatsu T. Symptom Improvement of ulceRative colitis after an Induction dose of UStekinumab in Japanese clinical practice (SIRIUS), measured using patient-reported outcomes: a prospective observational study. BMJ open. 2022. 12. e060081-1892
  • Nakase H, Hayashi Y, Hirayama D, Matsumoto T, Matsuura M, Iijima H, Matsuoka K, Ohmiya N, Ishihara S, Hirai F, et al. Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS). Journal of gastroenterology. 2022. 57. 174-184
Work history (1):
  • 2018/04 - 現在 Toho University Faculty of Medicine School of Medicine (Sakura) Professor
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page